Login

Categories

Careers Consumer Corporate Energy Entertainment Experts Financials Healthcare Industrial Law Markets Media Mining Private Equity Real Estates Sports Startups Technology Venture Capital

Recent Videos

00:00:00
Shield Therapeutics "ended 2022 in a very very productive state" - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:00:00
Shield Therapeutics 'delivered an excellent first half' with Accrufer powering ahead in the US - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:00:00
Shield Therapeutics talks extension of cash runway following US$10 million financing - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:00:00
Shield Therapeutics "couldn't be more pleased" with Viatris collaboration - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:00:00
Shield Therapeutics' present drive for US launch success of iron deficiency product Accrufer - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:00:00
Sienna Cancer Diagnostics (ASX:SDX) talks IVD test sales - Matthew Hoskin, CEO, Sienna Cancer Diagnostics Ltd
00:00:00
Sienna Cancer Diagnostics (ASX:SDX) update - Matthew Hoskin, CEO, Sienna Cancer Diagnostics Ltd
00:10:00
Geoscience INTEGRATOR: Your Comprehensive Mineral Exploration Data Solution | John McGaughey ,President of Mira Geoscience Ltd.
00:10:00
Green Mining Initiative Funds Awarded to MIRARCO | Nadia Mykytczuk - CEO of MIRARCO
00:10:00
Exclusive Interview with President & CEO Tim Heenan and Chairman Patrick Evans | Tim Heenan - PRESIDENT, CEO & DIRECTOR of Mirasol Resources Ltd.
00:10:00
Mitre Mining (ASX: MMC) Seizes Chilean Acquisition for Major Silver-Gold Resource Boost | Ray Shorrocks - Interim Executive Director of Mitre Mining Corporation Ltd.
00:10:00
HALO Trust and MMD Demining Sizer: Clearing Zimbabwe's Mines for a Safer Future | Chad Cretney - VP of MMD Mineral Sizing (Canada) Inc.
00:00:00
SELLAS Life Sciences Group - Licensed Asset Aims To Prolong Survival in Cancer Patients - Dr. Angelos Stergiou, President and CEO of SELLAS Life Sciences Group
00:00:00
Saniona President and CEO Rami Levin provides an overview of near-term milestones for key clinical programs - Rami Levin, CEO, Saniona
00:00:00
RLS Global - Naventus Life Science Summit - Karin Fischer, CEO, RLS Global
00:00:00
ReWalk Robotics Ltd RWLK CEO Larry Jasinski
00:00:00
RedHill Biopharma (NASDAQ: RDHL) Presenting the company - Gay Goldberg, CBO, Redhill Biopharma Ltd
00:00:00
Redx Pharma lands biggest deal to date with sale of KRAS inhibitor programme to Jazz Pharma - Lisa Anson Chief Executive Officer, Redx Pharma
00:00:00
Redx Pharma achieves milestone with dosing of first participant in Phase 1 clinical trial for RXC008 - Lisa Anson Chief Executive Officer, Redx Pharma
00:00:00
Redx Pharma begins testing lead drug in phase II trial for idiopathic pulmonary fibrosis - Lisa Anson Chief Executive Officer, Redx Pharma

© 2017 - Townhall + Tv